1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer
- Contribution to journal › Article
-
Mark
The bile duct and liver cancer ON-treatment surveillance of tumor evolution and response to systemic treatment (BILLIONSTARS) study
- Contribution to journal › Article
- 2023
-
Mark
Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer : the CHAMP study
- Contribution to journal › Article
-
Mark
Disease and Illness Trajectories of Pancreatic Cancer
(2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the CHAMP study
- Contribution to journal › Article
- 2022
-
Mark
Branching copy number evolution and parallel immune profiles across the regional tumor space of resected pancreatic cancer
- Contribution to journal › Article
-
Mark
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer
- Contribution to journal › Article
- 2020
-
Mark
Chemotherapy, host response and molecular dynamics in periampullary cancer : The CHAMP study
- Contribution to journal › Article
- 2019
-
Mark
Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome
- Contribution to journal › Article
- 2018
-
Mark
A translational effort to identify prognostic and predictive biomarkers in pancreatic cancer among RBM3-regulated genes
- Contribution to conference › Poster
